Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. Operating Income margin
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income margin | 3.2% | 188.0% | (169.7%) | (91.5%) | (37.7%) | (19.5%) | (21.2%) | (46.0%) | 33.2% | 36.1% | 29.7% | 30.5% | 27.4% | 35.4% | 37.8% | 28.1% | 42.1% | 55.7% | 38.9% | 30.9% |
Regeneron Pharmaceuticals, Inc. (REGN) Operating Income margin comparison analysis
REGN key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Regeneron Pharmaceuticals, Inc.'s Operating Income margin?
As of today, Microsoft Corp's last 12-month Operating Income margin is 28.9%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for Regeneron Pharmaceuticals, Inc. have been 41.1% over the past three years, and 40.9% over the past five years.
2) Is Regeneron Pharmaceuticals, Inc.'s Operating Income margin Good?
As of today, Regeneron Pharmaceuticals, Inc.'s Operating Income margin is 28.9%, which is higher than industry median of (916.0%). It indicates that Regeneron Pharmaceuticals, Inc.'s Operating Income margin is Good.